BACKGROUND AND PURPOSEThe non-psychotropic cannabinoid cannabichromene is known to activate the transient receptor potential ankyrin-type1 (TRPA1) and to inhibit endocannabinoid inactivation, both of which are involved in inflammatory processes. We examined here the effects of this phytocannabinoid on peritoneal macrophages and its efficacy in an experimental model of colitis.
EXPERIMENTAL APPROACHMurine peritoneal macrophages were activated in vitro by LPS. Nitrite levels were measured using a fluorescent assay; inducible nitric oxide (iNOS), cyclooxygenase-2 (COX-2) and cannabinoid (CB1 and CB2) receptors were analysed by RT-PCR (and/or Western blot analysis); colitis was induced by dinitrobenzene sulphonic acid (DNBS). Endocannabinoid (anandamide and 2-arachidonoylglycerol), palmitoylethanolamide and oleoylethanolamide levels were measured by liquid chromatographymass spectrometry. Colonic inflammation was assessed by evaluating the myeloperoxidase activity as well as by histology and immunohistochemistry.
KEY RESULTSLPS caused a significant production of nitrites, associated to up-regulation of anandamide, iNOS, COX-2, CB1 receptors and down-regulation of CB2 receptors mRNA expression. Cannabichromene significantly reduced LPS-stimulated nitrite levels, and its effect was mimicked by cannabinoid receptor and TRPA1 agonists (carvacrol and cinnamaldehyde) and enhanced by CB1 receptor antagonists. LPS-induced anandamide, iNOS, COX-2 and cannabinoid receptor changes were not significantly modified by cannabichromene, which, however, increased oleoylethanolamide levels. In vivo, cannabichromene ameliorated DNBS-induced colonic inflammation, as revealed by histology, immunohistochemistry and myeloperoxidase activity.
CONCLUSION AND IMPLICATIONSCannabichromene exerts anti-inflammatory actions in activated macrophages -with tonic CB1 cannabinoid signalling being negatively coupled to this effect -and ameliorates experimental murine colitis.
BJP
Nowadays
chemotherapy is the main treatment for osteosarcoma disease,
even if limited by the lack of selectivity between healthy and cancer
cells during the inhibition of cell division. Herein, we propose the
use of few-layer two-dimensional black phosphorous (2D bP) as an alternative
tool for osteosarcoma treatment and report how 2D bP can stimulate
newly forming bone tissue generation after osteosarcoma resection.
In our study, we have developed an in vitro model to evaluate the
efficacy of 2D bP material with and without near-infrared light irradiation
treatment, and we have demonstrated that the presence of 2D bP without
treatment inhibits the metabolic activity of osteosarcoma cells (SAOS-2)
while inducing both the proliferation and the osteogenic differentiation
of human preosteoblast cells (HOb) and mesenchymal stem cells. Furthermore,
we also propose an in vitro coculture model (SAOS-2 and HOb cell lines)
in order to study the effect of 2D bP on inflammatory response related
to cancer. On this coculture model, 2D bP may increase anti-inflammatory
cytokine generation (i.e., interleukin-10) and inhibit proinflammatory
mediators synthesis (i.e., interleukin-6), thus suggesting the opportunity
to prevent cancer-related inflammation. Finally, we have demonstrated
that 2D bP represents a promising candidate for future regenerative
medicine and anticancer applications.
Bromelain exerts antiproliferative and proapoptotic effects in colorectal carcinoma cells and chemopreventive actions in colon carcinogenesis in vivo. Bromelain-containing foods and/or bromelain itself may represent good candidates for colorectal cancer chemoprevention.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.